Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 03, 2024
Targeting LxCxE cleft pocket of retinoblastoma protein in M2 macrophages inhibits ovarian cancer progression.
Journal: bioRxiv : the preprint server for biology
Published: May 27, 2024
Targeting LxCxE Cleft Pocket of Retinoblastoma Protein in Immunosuppressive Macrophages Inhibits Ovarian Cancer Progression.
Journal: Cancer immunology research
Published: May 12, 2024
ARID1A promotes genomic stability through protecting telomere cohesion.
Journal: Nature communications
Published: April 25, 2019
Malignant Transformation of Endometriosis in the Ischioanal Fossa.
Journal: Case reports in obstetrics and gynecology
Published: January 07, 2018
Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells.
Journal: Cancer discovery
Published: May 02, 2016
Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 24, 2016
Postmenopausal Bleeding Resulting from Acute Myeloid Leukemia Infiltration of the Endometrium.
Journal: Delaware medical journal
Published: August 20, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026